Femasys Inc. (NASDAQ:FEMY) Given Average Recommendation of “Moderate Buy” by Brokerages

Femasys Inc. (NASDAQ:FEMY) has earned a consensus recommendation of “Moderate Buy” from the five ratings firms that are currently covering the company, MarketBeat reports. One equities research analyst has rated the stock with a sell rating and four have issued a buy rating on the company. The average twelve-month target price among brokers that have covered the stock in the last year is $5.50.

A number of brokerages have commented on FEMY. Weiss Ratings reiterated a “sell (e+)” rating on shares of Femasys in a research report on Thursday, January 22nd. Lake Street Capital initiated coverage on Femasys in a research note on Tuesday, March 3rd. They issued a “buy” rating and a $1.50 target price for the company. Finally, Wall Street Zen cut Femasys from a “hold” rating to a “sell” rating in a research report on Saturday.

Institutional Trading of Femasys

Several institutional investors have recently made changes to their positions in FEMY. Jane Street Group LLC bought a new stake in Femasys in the second quarter valued at about $82,000. Osaic Holdings Inc. bought a new position in Femasys during the second quarter worth about $45,000. Geode Capital Management LLC boosted its holdings in Femasys by 50.8% during the fourth quarter. Geode Capital Management LLC now owns 389,280 shares of the company’s stock valued at $224,000 after purchasing an additional 131,052 shares in the last quarter. Kovack Advisors Inc. acquired a new stake in Femasys during the fourth quarter valued at approximately $27,000. Finally, Banco BTG Pactual S.A. bought a new stake in shares of Femasys in the 4th quarter valued at approximately $88,000. 65.27% of the stock is currently owned by institutional investors and hedge funds.

Femasys Stock Down 3.2%

FEMY stock opened at $0.48 on Friday. Femasys has a twelve month low of $0.31 and a twelve month high of $1.39. The company has a quick ratio of 0.61, a current ratio of 1.16 and a debt-to-equity ratio of 0.01. The company has a market cap of $28.21 million, a PE ratio of -0.67 and a beta of -2.53. The business’s 50-day simple moving average is $0.55 and its 200 day simple moving average is $0.63.

About Femasys

Femasys International, Inc is a medical device company focused on the research, development and commercialization of innovative technologies for interventional women’s health applications. The company’s core activities center on creating minimally invasive diagnostic and therapeutic products designed to address uterine cavity evaluation and treatment and to improve outcomes in gynecological care.

The company’s flagship product, the FemVue® hydrosonography system, is a single-use catheter-based device that enhances visualization of the uterine cavity through saline infusion sonography.